Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Esperion Therapeutis.Inc. buy bundfuture

Start price
€7.78
17.10.21 / 50%
Target price
-
17.10.22
Performance (%)
3.34%
End price
€8.04
30.10.21
Summary
This prediction ended on 30.10.21 with a price of €8.04. With a performance of 3.34%, the BUY prediction by bundfuture for Esperion Therapeutis.Inc. closed with a slight gain. bundfuture has 50% into this prediction

Esperion Therapeutics, Inc. (NASDAQ: ESPR) is a biopharmaceutical company primarily focused on the development and commercialization of innovative lipid management therapies to address the unmet medical needs of patients with high cholesterol. With its flagship products, NEXLETOL® and NEXLIZET®, the company aims to provide alternative treatment options for individuals who cannot tolerate statins or require additional LDL-C lowering despite statin therapy. Esperion is driven by its commitment to improve cardiovascular health globally and maintains a steadfast dedication to researching and developing advanced cholesterol-lowering therapies.

Performance without dividends (%)
Name 1w 1m 1y
Esperion Therapeutis.Inc. 26.540% 26.540% 58.879%
iShares Core DAX® 1.883% 5.122% 21.667%
iShares Nasdaq 100 0.125% 2.574% 45.951%
iShares Nikkei 225® -0.201% 4.341% 28.806%
iShares S&P 500 0.728% 4.141% 34.630%

According to bundfuture what are the pros and cons of Esperion Therapeutis.Inc. for the foreseeable future?

Pros
Could be worthwhile Investment >10% per year
Cons

Comments by bundfuture for this prediction

In the thread Esperion Therapeutis.Inc. diskutieren

Buy Esperion Therapeutis.Inc.

In the thread Trading Esperion Therapeutis.Inc.
Prediction Buy
Perf. (%) 3.34%
Target price
Change
Ends at 17.10.22

Buy beendet

Stopped prediction by bundfuture for Esperion Therapeutis.Inc.

buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.98
18.01.24
-
18.01.25
-3.63%
20.01.24

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€1.25
25.06.23
-
25.06.24
15.66%
09.07.23

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.76
11.12.22
-
11.12.23
-6.82%
06.03.23

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€3.71
09.01.22
-
09.01.23
-11.02%
22.01.22

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€4.62
03.12.21
-
03.12.22
0.84%
11.12.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€10.69
19.09.21
-
19.09.22
-4.16%
03.10.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€11.78
23.08.21
-
23.08.22
-10.53%
05.09.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€12.11
08.08.21
-
08.08.22
-5.82%
22.08.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€24.58
13.12.20
-
-10.62%
14.01.21

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€23.64
29.11.20
€23.00
3.98%
13.12.20

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€24.62
15.11.20
€25.00
-3.98%
29.11.20

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€20.63
03.11.20
€24.00
04.11.21
19.34%
15.11.20

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€34.28
26.07.20
€36.00
09.08.20
-4.73%
09.08.20

Could be worthwhile Investment >10% per year
buy
Esperion Therapeutis.Inc.

Start price
Target price
Perf. (%)
€30.92
05.04.20
€29.00
22.04.20
20.70%
22.04.20

Could be worthwhile Investment >10% per year